Image

Virtual A2 Study for At Risk Children

Virtual A2 Study for At Risk Children

Recruiting
5 years and younger
All
Phase N/A

Powered by AI

Overview

The goal of this behavioral-interventional study is to learn if the Abecedarian Approach implemented virtually for children ages 0-5 with a history of Hypoxic Ischaemic Encephalopathy (HIE) and/or premature birth produces the same effects as when administered at in-person facilities.

Eligibility

Inclusion Criteria:

  1. IPNH-NDCP patients, including:
    • Term-born children diagnosed during the neonatal period with hypoxic-ischemic encephalopathy, or
    • premature children (born at less than 28 weeks gestational age).
  2. Parent or legal guardian will also be enrolled as a participant
  3. Parents must be English-speaking (able to provide consent and complete questionnaires).

Exclusion Criteria:

  1. Not suitable for study participation due to other reasons at the discretion of the investigator.
  2. Infants with chromosomal abnormalities, genetic syndromes (for example, such as Down Syndrome or Trisomy18) and major congenital malformations will be excluded.
  3. Infants with vision impairment will also be excluded from the study, as our study procedures do require intact vision to be able to complete.
  4. For parents or legal guardians, there are no exclusion criteria.

Study details
    Hypoxic Ischaemic Encephalopathy (HIE)
    Premature Birth
    Cerebral Palsy
    Neurological Disorder

NCT06643598

University of Wisconsin, Madison

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.